Luyan Pharma Co.,Ltd. (SHE:002788)

China flag China · Delayed Price · Currency is CNY
13.76
-0.40 (-2.82%)
Apr 29, 2026, 3:04 PM CST
70.72%
Market Cap 5.50B
Revenue (ttm) 21.25B
Net Income (ttm) 280.88M
Shares Out 388.52M
EPS (ttm) 0.72
PE Ratio 19.67
Forward PE n/a
Dividend 0.35 (2.47%)
Ex-Dividend Date Jul 10, 2025
Volume 29,989,060
Average Volume 69,015,801
Open 13.93
Previous Close 14.16
Day's Range 13.53 - 13.98
52-Week Range 7.90 - 28.29
Beta 0.31
RSI 43.42
Earnings Date Apr 21, 2026

About Luyan Pharma

Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen,... [Read more]

Sector Healthcare
Founded 1992
Employees 5,602
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002788
Full Company Profile

Financial Performance

In 2025, Luyan Pharma's revenue was 21.25 billion, an increase of 3.79% compared to the previous year's 20.47 billion. Earnings were 280.88 million, a decrease of -18.74%.

Financial Statements

News

There is no news available yet.